Digital Tenacity – Why CEOs must focus on digital transformation

One of my co-workers is nicknamed “the Honey Badger.” The reason? He is fearless, he never quits -- he is tenacious. I call this out because of a recent report published by Gartner: 2016 CEO Survey: The Year of Digital Tenacity.

Posted on May 25, 2016 in Mind of Jeff Gaus , Industry Watch by Jeff Gaus
Read More

The Most Startling Finding from Our State of Life Sciences Commercialization Report

Prolifiq recently conducted our First Annual State of Life Sciences Commercialization in order to: a) understand the landscape and b) establish a series of benchmarks for future comparison.

Posted on May 19, 2016 in Mind of Jeff Gaus , Industry Watch by Jeff Gaus
Read More

Innovators Wanted

If you are reading this…you are behind.

Posted on May 17, 2016 in Being Prolifiq , Industry Watch by Jon Brooks
Read More

Four Emerging Trends from eyeforpharma Barcelona 2016

At my fourth outing to eyeforpharma Barcelona, I was intrigued by this year’s theme of pharma becoming a trusted partner in the broader healthcare industry.

Historically, this event has been strongly focused on the themes of "multi-channel" and "digital” as they were the traditional flags to fly on the long march to Commercial Excellence. 

Posted on March 31, 2016 in Industry Watch by Jon Brooks
Read More

4 Shifts in the Life Sciences Industry Marketers Need to Watch

It has been 5+ years since the Supreme Court of the United States affirmed the Affordable Care Act (ACA) was the law of the land, the effects of this law are beginning to accelerate. And, we are beginning to see other laws affect the behavior of the industry.

Posted on November 23, 2015 in Industry Watch by Jeff Gaus
Read More

DTC Advertising – Physician Group Pushes Back

The USA differs from many countries in that direct to consumer (DTC) advertising, promoting the benefits of specific pharma therapies, is permitted by law. So, this means: television, radio, print, and digital communications are permitted as long as they follow the labeling rules.

In a surprising move, the American Medical Association (AMA) has voted to end DTC advertising
stating the advertising drives patients to more expensive medicines, drives up demand and raises overall costs.

Posted on November 17, 2015 in Industry Watch by Jeff Gaus
Read More

AdvaMed 2015: Thinking INSIDE the Box

I just returned from three days attending the AdvaMed 2015 conference; this year was special as it was the 40th anniversary of the group. This event did an excellent job acknowledging all the group stands for and has accomplished.

Posted on October 13, 2015 in Mind of Jeff Gaus , Industry Watch by Jeff Gaus
Read More

PharmaForce 2015: Patients at the Center

Two weeks ago we attended PharmaForce in Arlington, VA; overall, this was an excellent event with great content in the VIP Think Tank, the panel discussions and during the networking events. What I enjoyed most about this event was the mix of disciplines represented: sales leadership, marketing leadership, sales operations, marketing operations, analytics, and IT. Because of this, there was a lot of interaction between the speakers and the audience and among the audience members themselves.

Posted on September 9, 2015 in Mind of Jeff Gaus , Industry Watch by Jeff Gaus
Read More

Patient Outcomes: Wellness as a Service

I returned last week from co-chairing ExL’s Digital Marketing for Medical Devices conference and exhibit in Minneapolis with Medtronic’s Scott Klein. This was the 5th annual, and arguably the biggest and best exchange of ideas in the medical devices marketing community (so far). Jayson, Caroline, Sarah and the eXL folks are to be commended for another great event.

Posted on August 21, 2015 in Mind of Jeff Gaus , Industry Watch , People, Places & Things by Jeff Gaus
Read More

Team Based Selling: me to you vs. us to them

Several presentations at the latest life sciences conferences (ePharma summit, eyeforpharma Barcelona, Digital Marketing for Medical Devices and Digital Pharma West) have focused on the changes affecting the field reps and commercialization activities in general and Key Account Management (KAM) specifically.

Posted on June 10, 2015 in Being Prolifiq , Industry Watch by Jeff Gaus
Read More